Lin28 enhances de novo fatty acid synthesis to promote cancer progression via SREBP ‐1

Author:

Zhang Yang12ORCID,Li Chenchen2,Hu Chuanzhen3,Wu Qian4,Cai Yongping5,Xing Songge12,Lu Hui2,Wang Lin2,Huang De2,Sun Linchong6,Li Tingting2,He Xiaoping2,Zhong Xiuying6,Wang Junfeng7,Gao Ping16ORCID,Smith Zachary J3,Jia Weidong1ORCID,Zhang Huafeng12

Affiliation:

1. Anhui Key Laboratory of Hepatopancreatobiliary Surgery Department of General Surgery Anhui Provincial Hospital The First Affiliated Hospital of USTC University of Science and Technology of China Hefei China

2. Hefei National Laboratory for Physical Sciences at Microscale The CAS Key Laboratory of Innate Immunity and Chronic Disease Division of Molecular Medicine School of Life Sciences and Medical Center University of Science and Technology of China Hefei China

3. Department of Precision Machinery and Precision Instrumentation University of Science and Technology of China Hefei China

4. Shanghai Center for Bioinformation Technology Shanghai China

5. Department of Pathology School of Medicine Anhui Medical University Hefei China

6. Laboratory of Cancer and Stem Cell Metabolism School of Medicine Institutes for Life Sciences South China University of Technology Guangzhou China

7. High Magnetic Field Laboratory Chinese Academy of Sciences Hefei China

Funder

National Natural Science Foundation of China

Chinese Academy of Sciences

Publisher

EMBO

Subject

Genetics,Molecular Biology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3